These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28374029)

  • 1. Prediction of luciferase inhibitors by the high-performance MIEC-GBDT approach based on interaction energetic patterns.
    Chen F; Sun H; Liu H; Li D; Li Y; Hou T
    Phys Chem Chem Phys; 2017 Apr; 19(15):10163-10176. PubMed ID: 28374029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luciferase Advisor: High-Accuracy Model To Flag False Positive Hits in Luciferase HTS Assays.
    Ghosh D; Koch U; Hadian K; Sattler M; Tetko IV
    J Chem Inf Model; 2018 May; 58(5):933-942. PubMed ID: 29667823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Docking and MM/GBSA Rescoring Study of Ligand Recognition upon Binding Antithrombin.
    Zhang X; Perez-Sanchez H; Lightstone FC
    Curr Top Med Chem; 2017; 17(14):1631-1639. PubMed ID: 27852201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Analysis and Identification of False Positive Hits in Luciferase-Based Assays.
    Yang ZY; Dong J; Yang ZJ; Lu AP; Hou TJ; Cao DS
    J Chem Inf Model; 2020 Apr; 60(4):2031-2043. PubMed ID: 32202787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constructing and Validating High-Performance MIEC-SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery.
    Sun H; Pan P; Tian S; Xu L; Kong X; Li Y; Dan Li ; Hou T
    Sci Rep; 2016 Apr; 6():24817. PubMed ID: 27102549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-specific performance of MM-PBSA, MM-GBSA, and SIE in virtual screening.
    Virtanen SI; Niinivehmas SP; Pentikäinen OT
    J Mol Graph Model; 2015 Nov; 62():303-318. PubMed ID: 26550792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning on ligand-residue interaction profiles to significantly improve binding affinity prediction.
    Ji B; He X; Zhai J; Zhang Y; Man VH; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33758923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitors.
    Wichapong K; Rohe A; Platzer C; Slynko I; Erdmann F; Schmidt M; Sippl W
    J Chem Inf Model; 2014 Mar; 54(3):881-93. PubMed ID: 24490903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
    Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
    Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting fragment binding poses using a combined MCSS MM-GBSA approach.
    Haider MK; Bertrand HO; Hubbard RE
    J Chem Inf Model; 2011 May; 51(5):1092-105. PubMed ID: 21528911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving virtual screening results with MM/GBSA and MM/PBSA rescoring.
    Sahakyan H
    J Comput Aided Mol Des; 2021 Jun; 35(6):731-736. PubMed ID: 33983518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing binding of small molecules. II. Evaluating the potency of small molecules to combat resistance based on docking structures.
    Ding B; Li N; Wang W
    J Chem Inf Model; 2013 May; 53(5):1213-22. PubMed ID: 23570305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of chemical libraries for luciferase inhibitory activity.
    Auld DS; Southall NT; Jadhav A; Johnson RL; Diller DJ; Simeonov A; Austin CP; Inglese J
    J Med Chem; 2008 Apr; 51(8):2372-86. PubMed ID: 18363348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and dynamic simulation evaluation of Rohinitib - Cantharidin based novel HSF1 inhibitors for cancer therapy.
    Agarwal T; Annamalai N; Khursheed A; Maiti TK; Arsad HB; Siddiqui MH
    J Mol Graph Model; 2015 Sep; 61():141-9. PubMed ID: 26245696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.